Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 47 Breast Neoplasms 32 Colorectal Neoplasms 28 Prostatic Neoplasms 27 Lung Neoplasms 16 Hematopoietic and Lymphatic System Neoplasm 12 Hematologic Neoplasms 12 Ovarian Neoplasms 11 Uterine Cervical Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Lymphoma 7 Leukemia 7 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Depression 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Urinary Bladder Neoplasms 4 Mouth Neoplasms 4 Motor Activity 4 Melanoma 4 Malignant Solid Neoplasm 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Gastrointestinal Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Anxiety Disorders 4 Advanced Cancer 4

Interventions

Doxorubicin 18 Ifosfamide 13 Radiotherapy 8 Paclitaxel 7 pazopanib 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Etoposide 3 Epirubicin 3 Docetaxel 3 Carboplatin 3 trebananib 2 regorafenib 2 cixutumumab 2 cemiplimab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiosarcoma × Interviews as Topic × Clear all

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡